Rhenman & Partners Asset Management AB as of June 30, 2020
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 94 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub SHS | 4.5 | $42M | 750k | 55.58 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $40M | 138k | 290.31 | |
| UnitedHealth (UNH) | 3.3 | $31M | 105k | 294.95 | |
| Abbvie (ABBV) | 3.2 | $30M | 300k | 98.18 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $23M | 190k | 123.34 | |
| Bristol Myers Squibb (BMY) | 2.4 | $22M | 380k | 58.80 | |
| Novocure Ord Shs (NVCR) | 2.4 | $22M | 375k | 59.30 | |
| Esperion Therapeutics (ESPR) | 2.4 | $22M | 425k | 51.31 | |
| Humana (HUM) | 2.3 | $21M | 55k | 387.75 | |
| Alexion Pharmaceuticals | 2.3 | $21M | 190k | 112.24 | |
| Cigna Corp (CI) | 2.2 | $21M | 110k | 187.65 | |
| Macrogenics (MGNX) | 2.0 | $19M | 675k | 27.92 | |
| Nektar Therapeutics (NKTR) | 2.0 | $18M | 790k | 23.16 | |
| Gilead Sciences (GILD) | 1.9 | $18M | 230k | 76.94 | |
| Eli Lilly & Co. (LLY) | 1.9 | $17M | 105k | 164.18 | |
| Anthem (ELV) | 1.8 | $17M | 65k | 262.98 | |
| Abbott Laboratories (ABT) | 1.8 | $17M | 185k | 91.43 | |
| Axonics Modulation Technolog (AXNX) | 1.8 | $17M | 470k | 35.11 | |
| Abiomed | 1.8 | $16M | 68k | 241.56 | |
| Immunomedics | 1.8 | $16M | 460k | 35.44 | |
| Myokardia | 1.7 | $16M | 160k | 96.62 | |
| Biohaven Pharmaceutical Holding | 1.7 | $15M | 210k | 73.11 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.6 | $15M | 137k | 110.34 | |
| Guardant Health (GH) | 1.6 | $15M | 185k | 81.13 | |
| Centene Corporation (CNC) | 1.6 | $15M | 234k | 63.55 | |
| Acceleron Pharma | 1.6 | $15M | 155k | 95.27 | |
| CVS Caremark Corporation (CVS) | 1.6 | $15M | 227k | 64.97 | |
| Boston Scientific Corporation (BSX) | 1.6 | $14M | 410k | 35.11 | |
| Arena Pharmaceuticals Com New | 1.4 | $13M | 211k | 62.95 | |
| Seattle Genetics | 1.4 | $13M | 75k | 169.92 | |
| Merck & Co (MRK) | 1.3 | $12M | 160k | 77.33 | |
| Intra Cellular Therapies (ITCI) | 1.3 | $12M | 475k | 25.67 | |
| Medtronic SHS (MDT) | 1.3 | $12M | 131k | 91.70 | |
| Mirati Therapeutics | 1.2 | $11M | 100k | 114.17 | |
| Cooper Cos Com New | 1.2 | $11M | 40k | 283.65 | |
| Livanova SHS (LIVN) | 1.1 | $11M | 220k | 48.13 | |
| Adverum Biotechnologies | 1.1 | $10M | 500k | 20.88 | |
| Intuitive Surgical Com New (ISRG) | 1.0 | $9.7M | 17k | 569.82 | |
| Livongo Health SHS | 1.0 | $9.4M | 125k | 75.19 | |
| Iovance Biotherapeutics (IOVA) | 1.0 | $9.3M | 340k | 27.45 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $9.2M | 62k | 148.11 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $9.2M | 75k | 122.00 | |
| Aerie Pharmaceuticals | 0.9 | $8.7M | 590k | 14.76 | |
| Xencor (XNCR) | 0.9 | $8.4M | 260k | 32.39 | |
| Edwards Lifesciences (EW) | 0.9 | $8.3M | 120k | 69.11 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.9 | $8.2M | 926k | 8.87 | |
| Baxter International (BAX) | 0.9 | $8.2M | 95k | 86.11 | |
| Regeneron Pharmaceuticals (REGN) | 0.8 | $7.8M | 13k | 623.68 | |
| Hca Holdings (HCA) | 0.8 | $7.3M | 75k | 97.07 | |
| EXACT Sciences Corporation (EXAS) | 0.8 | $7.0M | 80k | 86.94 | |
| Thermo Fisher Scientific (TMO) | 0.7 | $6.9M | 19k | 362.32 | |
| Zimmer Holdings (ZBH) | 0.7 | $6.8M | 57k | 119.37 | |
| Bluebird Bio (BLUE) | 0.7 | $6.6M | 108k | 61.04 | |
| Sangamo Biosciences (SGMO) | 0.7 | $6.0M | 675k | 8.96 | |
| Alkermes SHS (ALKS) | 0.6 | $6.0M | 310k | 19.41 | |
| Fibrogen (FGEN) | 0.6 | $5.9M | 145k | 40.53 | |
| Silk Road Medical Inc Common (SILK) | 0.6 | $5.9M | 140k | 41.89 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $5.4M | 165k | 32.66 | |
| Glaukos (GKOS) | 0.6 | $5.4M | 140k | 38.42 | |
| Revance Therapeutics (RVNC) | 0.6 | $5.4M | 220k | 24.42 | |
| Becton, Dickinson and (BDX) | 0.5 | $5.0M | 21k | 239.29 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $4.8M | 90k | 53.48 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $4.8M | 62k | 78.23 | |
| Aimmune Therapeutics | 0.5 | $4.8M | 285k | 16.71 | |
| G1 Therapeutics (GTHX) | 0.5 | $4.6M | 190k | 24.26 | |
| Biogen Idec (BIIB) | 0.5 | $4.5M | 17k | 267.53 | |
| Radius Health Com New | 0.5 | $4.5M | 332k | 13.63 | |
| Epizyme | 0.5 | $4.3M | 265k | 16.06 | |
| Omnicell (OMCL) | 0.5 | $4.2M | 60k | 70.62 | |
| Incyte Corporation (INCY) | 0.4 | $4.2M | 40k | 103.97 | |
| Momenta Pharmaceuticals | 0.4 | $4.0M | 120k | 33.27 | |
| Meiragtx Holdings (MGTX) | 0.4 | $3.8M | 300k | 12.52 | |
| Amarin Corp Spons Adr New (AMRN) | 0.4 | $3.6M | 525k | 6.92 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.3 | $3.2M | 1.7M | 1.83 | |
| Myovant Sciences | 0.3 | $3.1M | 150k | 20.62 | |
| Shockwave Med (SWAV) | 0.3 | $2.8M | 60k | 47.37 | |
| Abeona Therapeutics | 0.3 | $2.7M | 925k | 2.91 | |
| Cellectis S A Spons Ads (CLLS) | 0.3 | $2.6M | 145k | 17.80 | |
| Uniqure Nv SHS (QURE) | 0.2 | $1.8M | 41k | 45.05 | |
| Viewray (VRAYQ) | 0.2 | $1.7M | 775k | 2.24 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $930k | 300k | 3.10 | |
| Chevron Corporation (CVX) | 0.0 | $265k | 3.0k | 89.11 | |
| Exxon Mobil Corporation (XOM) | 0.0 | $241k | 5.4k | 44.73 | |
| Qualcomm (QCOM) | 0.0 | $217k | 2.4k | 91.14 | |
| International Business Machines (IBM) | 0.0 | $192k | 1.6k | 120.98 | |
| Janus Henderson Group Ord Shs (JHG) | 0.0 | $183k | 8.6k | 21.17 | |
| Ford Motor Company (F) | 0.0 | $177k | 29k | 6.07 | |
| JPMorgan Chase & Co. (JPM) | 0.0 | $162k | 1.7k | 94.02 | |
| Disney Walt Com Disney (DIS) | 0.0 | $149k | 1.3k | 111.36 | |
| Pfizer (PFE) | 0.0 | $147k | 4.5k | 32.61 | |
| Anheuser Busch Inbev Sa Sponsored Adr (BUD) | 0.0 | $138k | 2.8k | 49.18 | |
| Nortonlifelock (GEN) | 0.0 | $137k | 6.9k | 19.78 | |
| Wells Fargo & Company (WFC) | 0.0 | $135k | 5.3k | 25.61 | |
| Halliburton Company (HAL) | 0.0 | $108k | 8.3k | 13.01 |
